# Probiotics Stress Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/probiotics-stress-randomized-trial-evidence-review
Category: evidence-review
Summary: Probiotics Stress Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are rand
Last reviewed: 2026-06-16
Reviewed by: Migaku Evidence Review
# Probiotics Stress Randomized Trial: What the Evidence Says

## Quick Answer

Probiotics Stress Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 randomized trial, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| A Novel Combination of Probiotic Supplements Reduces Gut Permeability, Oxidative Stress, and Inflammation in Undernourished Adults: A Randomized Controlled Trial | randomized trial | 2 | 2026-05-27 | 10.1002/fsn3.71915 |
| Metabolic Dysfunction-Associated Steatotic Liver Disease: An Update Narrative Review of the Therapeutic Potential of Combining Probiotics and Metformin | preclinical study | 4 | 2026-05-19 | 10.3390/biomedicines14051147 |

## What The Sources Report

- BMI CBC CFU CRP ESR GPx HC MDA MLR NLR RDW-SD TAC TOS WC 2024 2024 2015 2021 2021 2020 2017 2021 2018 2024 2021 Undernutrition, characterized by insufficient energy and nutrient intake, affects approximately 390 million adults globally, leading to underweight status, wasting, and increased morbidity (Hegazi et al. ; World Health Organization ). [Ahmadi‐Khorram Maryam (2026); evidence level 2]
- Specifically,has been shown to improve gut permeability,supports mucosal immunity and reduce inflammation, andwas found to promote weight gain in malnourished populations (Gauffin et al. ; Million et al. ; Pan et al. ; Vendt et al. ). [Ahmadi‐Khorram Maryam (2026); evidence level 2]
- Metabolic dysfunction-associated steatotic liver disease (MASLD) is currently recognized as one of the leading causes of chronic liver disease worldwide. [Mustika Syifa (2026); evidence level 4]
- The disease is strongly associated with obesity, insulin resistance, type 2 diabetes mellitus (T2DM), dyslipidemia, and sedentary lifestyles. [Mustika Syifa (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For probiotics stress randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Ahmadi‐Khorram Maryam (2026). A Novel Combination of Probiotic Supplements Reduces Gut Permeability, Oxidative Stress, and Inflammation in Undernourished Adults: A Randomized Controlled Trial. DOI: 10.1002/fsn3.71915. PMCID: PMC13239392. PMID: 42255712. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13239392/
- Mustika Syifa (2026). Metabolic Dysfunction-Associated Steatotic Liver Disease: An Update Narrative Review of the Therapeutic Potential of Combining Probiotics and Metformin. DOI: 10.3390/biomedicines14051147. PMCID: PMC13204792. PMID: 42193472. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13204792/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.